Skip to main content

2 Result(s)

within Article Remove this filter Lars Möllgård Remove this filter Medicine & Public Health Remove this filter

and

  1. Article

    Open Access

    “Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”

    Bengt Rasmussen, Gudrun Göhring, Elsa Bernard, Lars Nilsson, Magnus Tobiasson… in Leukemia (2022)

    Download PDF (695 KB) View Article

  2. No Access

    Article

    The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia

    An internal tandem duplication of FLT3 (FLT3/ITD) occurs in approximately 25% of newly diagnosed AML. PKC412 inhibits the growth of leukemic cell lines with FLT3 mutations such as the MV4-11. This study evalua...

    Lars Möllgård, Stefan Deneberg, Hareth Nahi… in Cancer Chemotherapy and Pharmacology (2008)